Docetaxel in Treating Patients With Metastatic Breast Cancer - Contacts and Locations

Home

Docetaxel in Treating Patients With Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00008411. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00008411

Locations


United States, Texas
	MD Anderson Cancer Center at University of Texas
	Houston, Texas, United States, 77030-4009
	University of Texas M.D. Anderson CCOP Research Base
	Houston, Texas, United States, 77030-4009

Sponsors and Collaborators

M.D. Anderson Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Edgardo Rivera, MD	M.D. Anderson Cancer Center